Long Term Administration of Inhaled Mannitol in Cystic Fibrosis - A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects
Phase of Trial: Phase III
Latest Information Update: 19 Jun 2017
At a glance
- Drugs Mannitol (Primary)
- Indications Cystic fibrosis
- Focus Registrational; Therapeutic Use
- Sponsors Pharmaxis
- 13 Jun 2017 Status changed from active, no longer recruiting to completed, according to a Pharmaxis media release.
- 13 Jun 2017 According to a Pharmaxis media release, additional data from the trial will be presented at the North American Cystic Fibrosis Conference in November, 2017.
- 13 Jun 2017 According to a Pharmaxis media release, based on the results from this study, the company is expecting a resubmission of the Bronchitol New Drug Application to the FDA in 2018.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History